Sopungsungi-won (SP) prevents the onset of hyperglycemia and hyperlipidemia in Zucker diabetic fatty rats

Archives of Pharmacal Research

Volumn 25, Issue 6, 2002, Pages 923-931

  Kim, Youn Young ^a   Kang, Hyo Joo ^a   Ko, Sung Kwon ^b   Chung, Sung Hyun ^a  

^a Kyung Hee University   (South Korea)

^b Chung Ang University   (South Korea)

Author keywords

Glucokinase; Glucose 6 phosphatase; GLUT4; Pancreatic cell; Sopungsungi won; Type 2 diabetes mellitus; ZDF rat

Indexed keywords

ANIMAL; ARTICLE; BLOOD; COMPARATIVE STUDY; HYPERGLYCEMIA; HYPERLIPIDEMIA; MALE; MEDICINAL PLANT; METHODOLOGY; NON INSULIN DEPENDENT DIABETES MELLITUS; ORIENTAL MEDICINE; PHYTOTHERAPY; RAT; ZUCKER RAT;

ANIMALS; DIABETES MELLITUS, TYPE 2; HYPERGLYCEMIA; HYPERLIPIDEMIAS; MALE; MEDICINE, ORIENTAL TRADITIONAL; PHYTOTHERAPY; PLANTS, MEDICINAL; RATS; RATS, ZUCKER;

EID: 0037666112     PISSN: 02536269     EISSN: 02536269     Source Type: Journal    
DOI: 10.1007/BF02977015     Document Type: Article

References (21)

1. Amos, A. F., McCarty, D. J. and Zimmet, P., The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Medicine, 14, S1-S85 (1997).
2. Baginski, E. S., Foa, P. P. and Zak, B., "Methods of enzymatic analysis," Vol 2, ed. By H.U. Bergmeyer, Academic Press, New York and London, p. 876 (1974).
3. 1 in subjects with abnormal glucose tolerance but normal fasting plasma glucose. Diabetes, 29, 272-277 (1980).
4. DeFronzo, R.A., Pathogenesis of type 2 diabetes: metabolic and molecular implications for identifying diabetes genes. Diabetes Reviews, 5, 177-269 (1997).
5. Groop, L. C., Bonadonna, R. C., DelPrato, S., Ratheiser, K., Zyck, K., Ferrannini, E. and DeFronzo, R. A., Glucose and free fatty acid metabolism in non-insulin dependent diabetes mellitus. Evidence for multiple sites of insulin resistance. J. Clin. Invest., 84, 205-213 (1989).
6. Hara, H., Miwa, I. and Okuda, J., Inhibition of rat glucokinase by alloxan and ninhydrin. Chem. Pharm. Bull., 34, 4731-4737 (1986).
7. Kasiske, B. L., ODonnell, M. P., Cleary, M. P. and Keane, W. F., Treatment of hyperlipidemia reduces glomerular injury in obese Zucker rats. Kidney International, 33, 667-672 (1998).
8. Klein, R., Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care, 18, 258-268 (1995) .
9. Lee, S. H., An, S. Y., Du, H. K. and Chung, S. H., Blood glucose lowering activity and mechanism of Sopungsungi-won (SPSGW) in db/db mouse. J. Appl. Pharmacol., 7, 335-341 (1999).
10. Lowry, O. H., Rosebrough, N. J., Farr, A. L. and Randall, R. J., Protein Measurement with the Folin Phenol reagent. J. Biol. Chem., 193, 265-275 (1951).
11. Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F. and Turner, R. C., Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentration in man. Diabetologia, 28, 412-419 (1985).
12. Nathan, D. M., Long-term complications of diabetes mellitus. The New England Journal of Medicine 328,1676-1685 (1993).
13. Oakes, N. D., Kennedy, C. J., Jenkins, A. B., Laybutt, D. R., Chisholm, D. J. and Kraegen, E. W., A new antidiabetic agent, BRL 4965, reduces lipid availability and improves insulin actions and glucoregulation in the rat. Diabetes, 43, 1203-1210 (1994)
14. Polonsky, K. S., Sturis, J. and Bell, G. I., Non-insulin dependent diabetes mellitus. A genetically programmed failure of the B cell to compensate for insulin resistance. The New England Journal of Medicine, 334, 777-783 (1996).
15. Randle, P. J., Hales, C. N., Garland, P. B. and Newsholme, E. A., The glucose fatty-acid cycle: Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet, 13, 7285-7290 (1963).
16. Seoane, J., Barbera, A., Telemaque-Potts, S., Newgard, C. B. and Guinovart, J. J., Glucokinase overexpression restores glucose utilization and storage in cultured hepatocytes from male Zucker diabetic fatty rats. J. Biol. Chem., 272, 31833-31838 (1999).
17. Shimizu, H., Tsuchiya, T., Sato, N., Shimomura, Y., Kobayashi, I. and Mori, M., Troglitazone reduces plasma leptin concentration but increases hunger in NIDDM patients. Diabetes Care, 21, 1470-1474 (1998).
18. UK Prospective Diabetes Study Group, UK Prospective Diabetes Study 16. Overview of 6 tears therapy of type II diabetes: a progressive disease. Diabetes, 44, 1249-1258 (1995).
19. UK Prospective Diabetes Study Group, Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet, 352, 837-853 (1998).
20. Wajima, T., "Rinsyo Kagaku Bunseki," Vol 5, ed. By M. Kitamura, M. Satio, and M. Niwa, Tokyo Kagaku Dojin, Tokyo, p. 116 (1973).
21. Wang, Q., Dryden, S. and Frankish, H.M., Increased feeding in fatty Zucker rats by the thiazolidinedione BRL 49653 (rosiglitazone) and the possible involvement of leptin and hypothalamic neuropeptide Y. Br. J. Pharmacol., 128, 1405-1410 (1997).